Related Experiment Video
Updated: May 24, 2026

Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium
Published on: September 1, 2015
Cystatin C levels in patients with dipper and nondipper hypertension
Serkan Ordu1, Hakan Ozhan, Recai Alemdar
1Department of Cardiology, Medicine Faculty, Duzce University, Duzce, Turkey.
Insights
Nondipper hypertension is linked to increased cardiovascular risk. This study found higher cystatin C levels in nondipper hypertension patients, suggesting it may predict this blood pressure pattern.
Area of Science:
- Cardiology
- Nephrology
- Biochemistry
Background:
- Nondipper hypertension presents a greater cardiovascular risk compared to normotension.
- Understanding biomarkers associated with nondipper hypertension is crucial for risk stratification.
Purpose of the Study:
- To investigate serum cystatin C levels in patients with dipper versus nondipper hypertension.
- To determine if cystatin C is associated with the nondipping blood pressure pattern.
Main Methods:
- Ambulatory blood pressure monitoring (ABPM) was used to classify 88 hypertensive patients into dipper and nondipper groups.
- Clinical, laboratory, and ABPM data were compared between the two groups.
- Statistical analyses, including regression, were performed to assess cystatin C's relationship with blood pressure patterns.
Main Results:
- Patients with nondipper hypertension were older than those with dipper hypertension.
- Serum cystatin C levels were significantly higher in the nondipper group.
- Cystatin C was independently associated with the nondipping pattern and negatively correlated with nocturnal systolic blood pressure fall.
Conclusions:
- Elevated serum cystatin C levels are observed in patients with nondipper hypertension.
- Cystatin C may serve as a predictor for the nondipping blood pressure phenotype in hypertensive individuals.
Objective:
Subjects with nondipper hypertension carry a higher risk of cardiovascular events than their normotensive counterparts. The present study was designed to investigate cystatin C levels in patients with dipper and nondipper hypertension.
Methods:
Eighty-eight consecutive patients who had been treated with antihypertensive drugs for at least 6 months were included in the study. Dipping and nondipping patterns were detected with ambulatory blood pressure monitoring. Clinical, laboratory, and ambulatory blood pressure monitoring data of patient groups with nondipper and dipper hypertension were compared.
Results:
Patients in the nondipper group were older than those in the dipper group. Serum cystatin C level was higher in the patients in the nondipper group. Cystatin C was negatively correlated with the rate of systolic blood pressure fall at night (r = -0.41; P < 0.001). Linear regression analyses revealed that only cystatin C level was a significant correlate of nocturnal systolic blood pressure decrease. Logistic regression analyses also showed that cystatin C was an independent predictor of nondipping pattern (odds ratio, 3.586; 95% confidence interval, 1.432-8.98; P = 0.006]).
Conclusion:
The present study showed that cystatin C is higher in patients with nondipper hypertension patients.
Related Concept Videos
Antihypertensive Drugs: Potassium-Sparing Diuretics
Serum Studies: Renal Function Tests
Nephrotic Syndrome II : Assessment and Medical Management
Hypertension III: Clinical Manifestations and Diagnostic Studies
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Diabetes Insipidus I: Introduction
